Results 191 to 192 of about 4,863 (192)
Some of the next articles are maybe not open access.
Siltuximab (Sylvant) for treatment of multicentric castleman's disease.
The Medical letter on drugs and therapeutics, 2016openaire +1 more source
Siltuximab - Erster Wirkstoff gegen die multizentrische Casteleman-Erkrankung in Sicht
Österreichische Apothekerzeitung, 2014openaire +1 more source